Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 24 | Caljouw Lynne JEVP, Chief HR Officer | Open-market sale | SELL | $86K 2,480 sh | Mar 20, 2026 |
| 24 | Stanton CarlDirector | Derivative conversion | C | $2.28M 2.53M sh | Mar 20, 2026 traded Mar 13, 2026 |
| 24 | Focus Impact Sponsor, LLC10% Owner | Derivative conversion | C | $3.21M 3.56M sh | Mar 20, 2026 traded Mar 13, 2026 |
| 24 | Terreri Donald JosephController, Chief Acct Officer | Tax withholding | F | $54K 12.6K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 23 | Moore MichaelPresident | Open-market sale | SELL | $570K 65.0K sh | Mar 20, 2026 traded Mar 20, 2026 |
| 23 | Middleton Piers DayerEVP & Chief Operating Officer | Grant or award | A | $500K 6,643 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 23 | Lane Kenneth ToddDirector, President & CEO | Tax withholding | F | $516K 19.7K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 23 | Moore MichaelPresident | Open-market sale | SELL | $371K 40.2K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 23 | Madan Gopal AjayChief Financial Officer | Open-market sale | SELL | $479K 51.6K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 22 | Bernstein HaroldPresident, R&D & CMO | Open-market sale · 10b5-1 plan | SELL | $297K 6,161 sh | Mar 20, 2026 traded Mar 20, 2026 |
| 21 | Benvenuti Raynard D.Director | Grant or award | A | — 51.8K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Hill Donna K.VP, Human Resources | Grant or award | A | — 39.2K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Lane Kenneth ToddDirector, President & CEO | Option exercise | M | — 50.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Nixon D. GailSenior VP, Human Resources | Option exercise | M | — 123.5K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Statham JamiSVP, General Counsel | Grant or award | A | — 80.6K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | de Figueiredo Joao MDirector | Grant or award | A | — 17 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Neagle MatthewChief Operating Officer | Grant or award | A | — 826.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 21 | Terreri Donald JosephController, Chief Acct Officer | Grant or award | A | — 25.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 21 | Lane Kenneth ToddDirector, President & CEO | Option exercise | M | — 50.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 20 | Camblong JurgiDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $21K 4,486 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Muken RossPresident | Open-market sale · 10b5-1 plan | SELL | $5,671 1,183 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Van Tuyl ChristopherChief Legal Officer | Open-market sale | SELL | $72K 2,877 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 20 | Toth PeterEVP, Chief Sustain & Dev Off | Open-market sale · 10b5-1 plan | SELL | $324K 3,000 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 20 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $2,913 608 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Valente ManuelaChief People Officer | Open-market sale · 10b5-1 plan | SELL | $1,818 380 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $2,907 608 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Van Well DaanChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $3,274 684 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Cardoza GeorgeChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $3,705 774 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 20 | Siegel Ian H.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $88K 34.4K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 19 | Travers DavidPresident and interim CFO | Open-market sale · 10b5-1 plan | SELL | $60K 23.7K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 19 | Hudson Daniel A.EVP & GENERAL COUNSEL | Grant or award | A | $603K 8,005 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 19 | Hudson Daniel A.EVP & GENERAL COUNSEL | Grant or award | A | $500K 6,643 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 19 | Etzler Todd A.Executive Vice President & GC | Grant or award | A | — 3,020 sh | Mar 20, 2026 traded Mar 17, 2026 |
| 19 | Stewart John REVP - Chief Financial Officer | Grant or award | A | — 6,714 sh | Mar 20, 2026 traded Mar 17, 2026 |
| 19 | Bernstein HaroldPresident, R&D & CMO | Open-market sale · 10b5-1 plan | SELL | $187K 3,795 sh | Mar 20, 2026 traded Mar 20, 2026 |
| 18 | Housman JeffreySee Remarks | Option exercise | M | $1.11M 20.0K sh | Mar 20, 2026 traded Mar 20, 2026 |
| 18 | Pierozzi LisaDirector | Gift | G | — 38.4K sh | Mar 20, 2026 traded Mar 17, 2026 |
| 17 | Hogan Michael JamesChief Business Officer | Open-market sale · 10b5-1 plan | SELL | $78K 1,800 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 17 | Dolan John JosephChief Financial Officer | Grant or award | A | — 73.5K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 17 | Tabak ShawnCHIEF FINANCIAL OFFICER | Option exercise | M | — 124.0K sh | Mar 20, 2026 traded Mar 19, 2026 |